Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
26.03
-0.02 (-0.08%)
At close: Apr 15, 2025, 4:00 PM
26.19
+0.16 (0.61%)
After-hours: Apr 15, 2025, 8:00 PM EDT
Smith & Nephew Employees
Smith & Nephew had 18,060 employees as of December 31, 2024. The number of employees decreased by 1,021 or -5.35% compared to the previous year.
Employees
18,060
Change (1Y)
-1,021
Growth (1Y)
-5.35%
Revenue / Employee
$321,705
Profits / Employee
$22,813
Market Cap
11.48B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 18,060 | -1,021 | -5.35% |
Dec 31, 2023 | 19,081 | -13 | -0.07% |
Dec 31, 2022 | 19,094 | 118 | 0.62% |
Dec 31, 2021 | 18,976 | 395 | 2.13% |
Dec 31, 2020 | 18,581 | 551 | 3.06% |
Dec 31, 2019 | 18,030 | 1,349 | 8.09% |
Dec 31, 2018 | 16,681 | 348 | 2.13% |
Dec 31, 2017 | 16,333 | 749 | 4.81% |
Dec 31, 2016 | 15,584 | 898 | 6.11% |
Dec 31, 2015 | 14,686 | 1,218 | 9.04% |
Dec 31, 2014 | 13,468 | 2,432 | 22.04% |
Dec 31, 2013 | 11,036 | 559 | 5.34% |
Dec 31, 2012 | 10,477 | -266 | -2.48% |
Dec 31, 2011 | 10,743 | 571 | 5.61% |
Dec 31, 2010 | 10,172 | 408 | 4.18% |
Dec 31, 2009 | 9,764 | 7 | 0.07% |
Dec 31, 2008 | 9,757 | 567 | 6.17% |
Dec 31, 2007 | 9,190 | 360 | 4.08% |
Dec 31, 2006 | 8,830 | 212 | 2.46% |
Dec 31, 2005 | 8,618 | 752 | 9.56% |
Dec 31, 2004 | 7,866 | 415 | 5.57% |
Feb 16, 2003 | 7,451 | -55 | -0.73% |
Dec 31, 2002 | 7,506 | -420 | -5.30% |
Dec 31, 2001 | 7,926 | -2,509 | -24.04% |
Dec 31, 2000 | 10,435 | -778 | -6.94% |
Dec 31, 1999 | 11,213 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
HCA Healthcare | 316,000 |
Thermo Fisher Scientific | 125,000 |
Medtronic | 95,000 |
AstraZeneca | 92,900 |
Sanofi | 82,878 |
Novartis AG | 75,883 |
Becton, Dickinson and Company | 73,000 |
GSK plc | 68,629 |
SNN News
- 12 days ago - Trump tariffs: these two European healthcare stocks face the highest US revenue exposure - Invezz
- 5 weeks ago - Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025 - GlobeNewsWire
- 5 weeks ago - Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025 - GlobeNewsWire
- 5 weeks ago - New report confirms Smith+Nephew's OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty - GlobeNewsWire
- 6 weeks ago - Wound Care Market Size is Expected to Reach USD 32.75 Billion by 2033, Growing at a CAGR of 3.94%: Straits Research - GlobeNewsWire
- 7 weeks ago - Smith & Nephew plc (SNN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - UK's Smith+Nephew beats annual profit expectations - Reuters
- 2 months ago - Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand - GlobeNewsWire